BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18662841)

  • 1. A set of new amino acid descriptors applied in prediction of MHC class I binding peptides.
    Liang G; Yang L; Chen Z; Mei H; Shu M; Li Z
    Eur J Med Chem; 2009 Mar; 44(3):1144-54. PubMed ID: 18662841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
    Liang G; Chen G; Niu W; Li Z
    Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides.
    Liang G; Yang L; Kang L; Mei H; Li Z
    Amino Acids; 2009 Oct; 37(4):583-91. PubMed ID: 18821054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new sequence representation as applied in better specificity elucidation for human immunodeficiency virus type 1 protease.
    Liang GZ; Li SZ
    Biopolymers; 2007; 88(3):401-12. PubMed ID: 17206631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity.
    Hattotuwagama CK; Guan P; Doytchinova IA; Flower DR
    Org Biomol Chem; 2004 Nov; 2(22):3274-83. PubMed ID: 15534705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
    Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
    J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
    Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
    Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of T-cell epitopes based on least squares support vector machines and amino acid properties.
    Li S; Yao X; Liu H; Li J; Fan B
    Anal Chim Acta; 2007 Feb; 584(1):37-42. PubMed ID: 17386582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
    Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
    Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201.
    Guan P; Doytchinova IA; Walshe VA; Borrow P; Flower DR
    J Med Chem; 2005 Nov; 48(23):7418-25. PubMed ID: 16279801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
    Doytchinova IA; Flower DR
    Proteins; 2002 Aug; 48(3):505-18. PubMed ID: 12112675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.
    Christensen JK; Lamberth K; Nielsen M; Lundegaard C; Worning P; Lauemøller SL; Buus S; Brunak S; Lund O
    Neural Comput; 2003 Dec; 15(12):2931-42. PubMed ID: 14629874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural prediction of peptides bound to MHC class I.
    Fagerberg T; Cerottini JC; Michielin O
    J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and predicting interactions between the human amphiphysin SH3 domains and their peptide ligands based on amino acid information.
    Cai J; Ou R; Xu YS; Yang L; Lin Z; Shu M
    J Pept Sci; 2010 Nov; 16(11):627-32. PubMed ID: 20853307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
    He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
    Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Bayesian neural network models of MHC class II peptide binding.
    Burden FR; Winkler DA
    J Mol Graph Model; 2005 Jun; 23(6):481-9. PubMed ID: 15878832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.